Page 1 of 70
NR 565 ADVANCED PHARMACOLOGY FUNDAMENTALS
MIDTERM EXAM 2026/2027 COMPLETE (150) CURRENT
TESTING QUESTIONS AND CORRECT ANSWERS WITH
DETAILED RATIONALES.
PHARMACOLOGY
Prepare effectively for the NR 565 Midterm Exam in Chamberlain Advanced
Pharmacology with this focused study resource. It supports review of
pharmacokinetics, pharmacodynamics, medication classes, therapeutic effects,
adverse reactions, drug interactions, and safe prescribing principles. Use the material
to reinforce your pharmacology knowledge, review high-yield topics, and identify
areas that may require additional study. This resource is suited for Chamberlain
nursing students, advanced practice nursing learners, and candidates preparing for
the NR 565 Advanced Pharmacology midterm examination.
MULTIPLE CHOICE.
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS (Questions 1–
30)
1. A drug with a half-life of 4 hours is administered at a dose of 100 mg.
Approximately how much of the drug will remain in the body after 16
hours?
• A. 50 mg
• B. 25 mg
• C. 12.5 mg
• D. 6.25 mg
Answer: D. 6.25 mg
Rationale: After each half-life, 50% of the drug remains. After 16 hours (4
half-lives): 100 mg → 50 mg → 25 mg → 12.5 mg → 6.25 mg. Half-life
calculations are essential for determining dosing intervals and time to
steady state.
, Page 2 of 70
2. Which of the following statements best describes the volume of
distribution (Vd) of a drug?
• A. The actual volume of blood in the body
• B. The apparent volume in which a drug is distributed based on the
concentration in plasma
• C. The volume of the central compartment only
• D. The total body water volume
Answer: B. The apparent volume in which a drug is distributed based on
the concentration in plasma
Rationale: Volume of distribution (Vd) is a theoretical volume that relates
the amount of drug in the body to the concentration of drug in plasma. A
high Vd (>42 L) indicates extensive tissue distribution (e.g., lipophilic
drugs); a low Vd indicates confinement to the vascular compartment.
3. A patient with hepatic cirrhosis has impaired metabolism of a drug that
is highly protein-bound. What change in the drug's pharmacokinetics
should the provider anticipate?
• A. Decreased half-life
• B. Increased free drug concentration due to decreased albumin
production
• C. Decreased volume of distribution
• D. Increased renal excretion
Answer: B. Increased free drug concentration due to decreased albumin
production
Rationale: Hepatic cirrhosis reduces albumin synthesis, increasing the
unbound (free) fraction of highly protein-bound drugs. This can lead to
enhanced pharmacological effect and toxicity despite normal total drug
concentrations. Dosage reduction is often required.
, Page 3 of 70
4. Which CYP450 enzyme is responsible for metabolizing the largest
number of drugs?
• A. CYP1A2
• B. CYP3A4
• C. CYP2D6
• D. CYP2C9
Answer: B. CYP3A4
Rationale: CYP3A4 is the most abundant CYP450 enzyme in the liver and
intestines, metabolizing approximately 50% of all drugs. It is involved in
the metabolism of statins, calcium channel blockers, benzodiazepines,
and many other medications.
5. A patient is started on a new medication that is a strong CYP3A4
inhibitor. Which of the following drugs would require a dosage reduction
due to this interaction?
• A. Simvastatin
• B. Acetaminophen
• C. Metformin
• D. Lisinopril
Answer: A. Simvastatin
Rationale: Simvastatin is metabolized by CYP3A4. Co-administration with
a strong CYP3A4 inhibitor (e.g., ketoconazole, clarithromycin, grapefruit
juice) significantly increases simvastatin levels, increasing the risk of
myopathy and rhabdomyolysis. Simvastatin dose should be limited to 20
mg when used with strong CYP3A4 inhibitors.
6. What is the therapeutic index of a drug?
• A. The ratio of ED50 to LD50
, Page 4 of 70
• B. The ratio of the toxic dose to the therapeutic dose
• C. The dose required to produce a therapeutic effect in 50% of patients
• D. The time required for the drug to reach steady state
Answer: B. The ratio of the toxic dose to the therapeutic dose
Rationale: The therapeutic index (TI) is the ratio of the dose that produces
toxicity in 50% of the population (TD50) to the dose that produces a
therapeutic effect in 50% of the population (ED50). A narrow TI (e.g.,
warfarin, digoxin, lithium) requires careful monitoring to avoid toxicity.
7. Which of the following factors would INCREASE the volume of
distribution of a drug?
• A. High plasma protein binding
• B. High lipophilicity
• C. High molecular weight
• D. Ionization at physiological pH
Answer: B. High lipophilicity
Rationale: Lipophilic drugs readily cross cell membranes and distribute
into adipose tissue and other compartments, resulting in a larger volume
of distribution. Hydrophilic drugs and those with high protein binding tend
to have a smaller Vd.
8. A drug is administered intravenously and has a half-life of 6 hours.
Approximately how long will it take to reach 95% steady state?
• A. 12 hours
• B. 18 hours
• C. 24 hours
• D. 30 hours
NR 565 ADVANCED PHARMACOLOGY FUNDAMENTALS
MIDTERM EXAM 2026/2027 COMPLETE (150) CURRENT
TESTING QUESTIONS AND CORRECT ANSWERS WITH
DETAILED RATIONALES.
PHARMACOLOGY
Prepare effectively for the NR 565 Midterm Exam in Chamberlain Advanced
Pharmacology with this focused study resource. It supports review of
pharmacokinetics, pharmacodynamics, medication classes, therapeutic effects,
adverse reactions, drug interactions, and safe prescribing principles. Use the material
to reinforce your pharmacology knowledge, review high-yield topics, and identify
areas that may require additional study. This resource is suited for Chamberlain
nursing students, advanced practice nursing learners, and candidates preparing for
the NR 565 Advanced Pharmacology midterm examination.
MULTIPLE CHOICE.
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS (Questions 1–
30)
1. A drug with a half-life of 4 hours is administered at a dose of 100 mg.
Approximately how much of the drug will remain in the body after 16
hours?
• A. 50 mg
• B. 25 mg
• C. 12.5 mg
• D. 6.25 mg
Answer: D. 6.25 mg
Rationale: After each half-life, 50% of the drug remains. After 16 hours (4
half-lives): 100 mg → 50 mg → 25 mg → 12.5 mg → 6.25 mg. Half-life
calculations are essential for determining dosing intervals and time to
steady state.
, Page 2 of 70
2. Which of the following statements best describes the volume of
distribution (Vd) of a drug?
• A. The actual volume of blood in the body
• B. The apparent volume in which a drug is distributed based on the
concentration in plasma
• C. The volume of the central compartment only
• D. The total body water volume
Answer: B. The apparent volume in which a drug is distributed based on
the concentration in plasma
Rationale: Volume of distribution (Vd) is a theoretical volume that relates
the amount of drug in the body to the concentration of drug in plasma. A
high Vd (>42 L) indicates extensive tissue distribution (e.g., lipophilic
drugs); a low Vd indicates confinement to the vascular compartment.
3. A patient with hepatic cirrhosis has impaired metabolism of a drug that
is highly protein-bound. What change in the drug's pharmacokinetics
should the provider anticipate?
• A. Decreased half-life
• B. Increased free drug concentration due to decreased albumin
production
• C. Decreased volume of distribution
• D. Increased renal excretion
Answer: B. Increased free drug concentration due to decreased albumin
production
Rationale: Hepatic cirrhosis reduces albumin synthesis, increasing the
unbound (free) fraction of highly protein-bound drugs. This can lead to
enhanced pharmacological effect and toxicity despite normal total drug
concentrations. Dosage reduction is often required.
, Page 3 of 70
4. Which CYP450 enzyme is responsible for metabolizing the largest
number of drugs?
• A. CYP1A2
• B. CYP3A4
• C. CYP2D6
• D. CYP2C9
Answer: B. CYP3A4
Rationale: CYP3A4 is the most abundant CYP450 enzyme in the liver and
intestines, metabolizing approximately 50% of all drugs. It is involved in
the metabolism of statins, calcium channel blockers, benzodiazepines,
and many other medications.
5. A patient is started on a new medication that is a strong CYP3A4
inhibitor. Which of the following drugs would require a dosage reduction
due to this interaction?
• A. Simvastatin
• B. Acetaminophen
• C. Metformin
• D. Lisinopril
Answer: A. Simvastatin
Rationale: Simvastatin is metabolized by CYP3A4. Co-administration with
a strong CYP3A4 inhibitor (e.g., ketoconazole, clarithromycin, grapefruit
juice) significantly increases simvastatin levels, increasing the risk of
myopathy and rhabdomyolysis. Simvastatin dose should be limited to 20
mg when used with strong CYP3A4 inhibitors.
6. What is the therapeutic index of a drug?
• A. The ratio of ED50 to LD50
, Page 4 of 70
• B. The ratio of the toxic dose to the therapeutic dose
• C. The dose required to produce a therapeutic effect in 50% of patients
• D. The time required for the drug to reach steady state
Answer: B. The ratio of the toxic dose to the therapeutic dose
Rationale: The therapeutic index (TI) is the ratio of the dose that produces
toxicity in 50% of the population (TD50) to the dose that produces a
therapeutic effect in 50% of the population (ED50). A narrow TI (e.g.,
warfarin, digoxin, lithium) requires careful monitoring to avoid toxicity.
7. Which of the following factors would INCREASE the volume of
distribution of a drug?
• A. High plasma protein binding
• B. High lipophilicity
• C. High molecular weight
• D. Ionization at physiological pH
Answer: B. High lipophilicity
Rationale: Lipophilic drugs readily cross cell membranes and distribute
into adipose tissue and other compartments, resulting in a larger volume
of distribution. Hydrophilic drugs and those with high protein binding tend
to have a smaller Vd.
8. A drug is administered intravenously and has a half-life of 6 hours.
Approximately how long will it take to reach 95% steady state?
• A. 12 hours
• B. 18 hours
• C. 24 hours
• D. 30 hours
